- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Windlas Biotech's committee approved granting 5,70,500 stock options to eligible employees under its 'Windlas Plan 2025'. Each option converts to one Rs 5 equity share, vesting over four years. This move supports employee retention and could increase future shares outstanding.